Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: May 14, 2024
Open Peer Review Period: May 14, 2024 - Jul 9, 2024
Date Accepted: Oct 5, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Effect of a Feedback Visit and a Clinical Decision Support System Based on Antibiotic Prescription Audit in Primary Care: Multiarm Cluster-Randomized Controlled Trial

Jeanmougin P, Larramendy S, Fournier JP, Gaultier A, Rat C

Effect of a Feedback Visit and a Clinical Decision Support System Based on Antibiotic Prescription Audit in Primary Care: Multiarm Cluster-Randomized Controlled Trial

J Med Internet Res 2024;26:e60535

DOI: 10.2196/60535

PMID: 39693139

PMCID: 11694052

Effect of a Feedback Visit and a Clinical Decision Support System-based on Antibiotic Prescription Audit in Primary Care: a Multi-arm Cluster-Randomized Trial.

  • Pauline Jeanmougin; 
  • Stéphanie Larramendy; 
  • Jean-Pascal Fournier; 
  • Aurélie Gaultier; 
  • Cédric Rat

ABSTRACT

Background:

While numerous antimicrobial stewardship programs aim to decrease inappropriate antibiotic prescriptions, evidence of their positive impact is crucial.

Objective:

To evaluate multifaceted antibiotic stewardship interventions for inappropriate systemic antibiotic prescription in primary care.

Methods:

A cluster-randomized, open-label, controlled trial of 2501 general practitioners (GPs) in western France was conducted from July 2019 to January 2021. Two interventions were studied: the standard intervention (health insurance representative visit with prescription feedback and delivery of a treatment leaflet for cystitis and tonsillitis) and the second intervention (Clinical Decision Support System [CDSS]-based visit with prescription feedback and CDSS demonstration on antibiotic prescribing). The control group received no intervention. Data on systemic antibiotic dispensing were obtained from the Health National Insurance System (Système National d'Information Inter-Régimes de l'Assurance Maladie, SNIIRAM) database. The overall antibiotic volume dispensed per GP at 12 months was compared between arms using ANCOVA adjusted for annual antibiotic prescription volume at baseline.

Results:

Overall, 2501 GPs were randomized (mean age 53.4 years; 1099 women [43.9%]). At 12 months, the mean volume of systemic antibiotics per GP decreased by 209.1 DDD (95% CI -319.8 to -98.3, p<0.001) in the CDSS-based visit group compared with the control group. The decrease in the mean volume of systematic antibiotics dispensed per GP was not significantly different between the standard visit group and the control group (114.8 DDD; 95% CI -231.8 to 2.1; p=0.056).

Conclusions:

A health insurance visit combining feedback and a CDSS demonstration resulted in a 4.2% reduction in the total volume of systematic antibiotic prescriptions at 12 months. Clinical Trial: ClinicalTrials.gov Identifier: NCT04028830.


 Citation

Please cite as:

Jeanmougin P, Larramendy S, Fournier JP, Gaultier A, Rat C

Effect of a Feedback Visit and a Clinical Decision Support System Based on Antibiotic Prescription Audit in Primary Care: Multiarm Cluster-Randomized Controlled Trial

J Med Internet Res 2024;26:e60535

DOI: 10.2196/60535

PMID: 39693139

PMCID: 11694052

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.